The European Cancer Congress 2015

login
My congress planner
close
Forgot password

Create account

Searchable Programme for ECC2015

Keyword / Author:
  • 26
    SAT
    07:45 – 08:30
    Basic Science/Translational Research

    Teaching Lecture: Use of Liquid Biopsies

    Chair: C. Caldas (United Kingdom)

    Speaker: C. Dive (United Kingdom)

  • 26
    SAT
    10:30 – 12:30
    Basic Science/Translational Research

    Society Session: European Association for Cancer Research (EACR) – Clinical and Biological Implications of Intratumor Heterogeneity

    Chair: J. Seoane (Spain)

    Chair: C. Caldas (United Kingdom)

    10:30
    The new genome driver-based classification of breast cancer
    Speaker: C. Caldas (United Kingdom)
    Display Presentation Details

    11:00
    Cancer genomes in the clinic
    Speaker: A.V. Biankin (United Kingdom)
    Display Presentation Details

    11:30
    Intratumour macro- and microheterogeneity: the ultimate challenge for precision cancer medicine?
    Speaker: M. Gerlinger (United Kingdom)
    Display Presentation Details

    12:00
    Impact of intratumor heterogeneity in glioblastoma relapse
    Speaker: J. Seoane (Spain)

  • 27
    SUN
    08:00 – 08:45
    Basic Science/Translational Research

    Teaching Lecture: Epigenetics in Cancer Genesis

    Chair: V. Jendrossek (Germany)

    Speaker: M. Esteller (Spain)

  • 28
    MON
    08:00 – 08:45
    Basic Science/Translational Research

    Teaching Lecture: How Can We Address Tumour Heterogeneity and Clonal Evolution When Treating Cancer?

    Chair: C. von Kalle (Germany)

    Speaker: N. McGranahan (United Kingdom)
    Display Presentation Details

  • 29
    TUE
    09:00 – 10:50
    Abstract nr
    Basic Science/Translational Research

    Proffered Paper Session: Basic Science/Translational Research

    Chair: A. Berns (Netherlands)

    Chair: C. Caldas (United Kingdom)

    09:00
    100
    Understanding aggressive colorectal cancers by gene expression analysis of cancer stem cells
    Speaker: J. Manhas (India)
    Display abstract

    09:15
    101
    Combined inhibition of IGF1R and EGFR signaling overcomes the resistance to 3rd-generation EGFR kinase inhibitors caused by IGF1R activation
    Speaker: S. Park (Korea)
    Display abstract

    09:30
    102
    IL-6 receptor antibody enhances the effect of TKI against renal cell carcinoma
    Speaker: K. Ishibashi (Japan)
    Display abstract

    09:45
    Discussant : A. Berns (Netherlands)

    09:55
    103
    The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis
    Speaker: E. Thiele Orberg (USA)
    Display abstract

    10:10
    104
    CDH2 negative esophageal squamous cell carcinoma with cytotoxic T-lymphocyte signatures is a good responder subtype to definitive chemoradiotherapy
    Speaker: Y. Tanaka (Japan)
    Display abstract

    10:25
    105
    Targeting phosphatidylserine-mediated immune suppression enhances the efficacy of immune checkpoint blockade in preclinical tumor models of melanoma and breast
    Speaker: J. Hutchins (USA)
    Display abstract

    10:40
    Discussant : C. Caldas (United Kingdom)

Print all results list